Safety and Suitability of Infant Formula Manufactured from Extensively Hydrolyzed Whey Protein Compared to Intact Protein: A Combined Analysis of Two Randomized Controlled Studies
Nutrients · 12.01.2024 · 16 (2) · 245
DOI: 10.3390/nu16020245 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 12.01.2024. Verfasst von Manja Fleddermann und 2 weiteren Autor:innen. Beteiligte Einrichtung: HiPP GmbH & Co. Vertrieb KG, Georg-Hipp-Str. 7, 85276 Pfaffenhofen an der Ilm, Germany. Hauptthemen laut MEDLINE: Infant Formula, Research Design. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HiPP GmbH & Co. Vertrieb KG, Else Kröner-Fresenius Foundation, LMU Medical Faculty.
Abstract (Originalsprache)
Our aim was to assess the nutritional safety and suitability of an infant formula manufactured from extensively hydrolyzed protein in comparison to infant formula manufactured from intact protein (both with low and standard protein content). We performed a combined analysis of raw data from two randomized infant feeding studies. An analysis of covariance (ANCOVA) model was used to determine the non-inferiority of daily weight gain (primary outcome; margin −3 g/day), with the intervention group as a fixed factor and geographic region, sex, and baseline weight as covariates (main model). The data of 346 infants exposed to the formula were included in the analysis. The sample size of the per-protocol analysis with 184 infants was too small to achieve sufficient statistical power. The lower limit of the 97.5% confidence interval (−0.807) of the mean group difference in daily weight gain (i.e., 2.22 g/day) was above the −3 g/day margin (full analysis set). Further anthropometric parameters did not differ between the infant formula groups throughout the study. Growth was comparable to breastfed infants. We conclude that the infant formula manufactured from extensively hydrolyzed protein meets infant requirements for adequate growth and does not raise any safety concerns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HiPP GmbH & Co. Vertrieb KG, Georg-Hipp-Str. 7, 85276 Pfaffenhofen an der Ilm, Germany.
- AK Statistics, Kreppe 2, 85276 Pfaffenhofen an der Ilm, Germany.
- Division of Metabolic and Nutritional Medicine, Dr. von Hauner Children's Hospital, University of Munich Medical Center, Ludwig-Maximilians-Universität München, Lindwurmstr. 4, 80337 Muenchen, Germany.
ORCID-Profile: Berthold Koletzko
Förderung
- HiPP GmbH & Co. Vertrieb KG
- Else Kröner-Fresenius Foundation
- LMU Medical Faculty
- LMU University Hospitals
Zitieren
APA
Fleddermann, M., Knoll, A., & Koletzko, B. (2024). Safety and Suitability of Infant Formula Manufactured from Extensively Hydrolyzed Whey Protein Compared to Intact Protein: A Combined Analysis of Two Randomized Controlled Studies. Nutrients, 16(2), 245. https://doi.org/10.3390/nu16020245
Vancouver
Fleddermann M, Knoll A, Koletzko B. Safety and Suitability of Infant Formula Manufactured from Extensively Hydrolyzed Whey Protein Compared to Intact Protein: A Combined Analysis of Two Randomized Controlled Studies. Nutrients. 2024;16(2):245. doi:10.3390/nu16020245
BibTeX
@article{Fleddermann2024,
author = {Fleddermann, Manja and Knoll, Anette and Koletzko, Berthold},
title = {Safety and Suitability of Infant Formula Manufactured from Extensively Hydrolyzed Whey Protein Compared to Intact Protein: A Combined Analysis of Two Randomized Controlled Studies},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {2},
pages = {245},
doi = {10.3390/nu16020245}
}
EUVIMED